Yanlin Li
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Impact of NSAID type, initiation timing, duration and dose on clinical outcomes of immunotherapy in NSCLC: a multicenter two-cohort study.
Journal: Journal for immunotherapy of cancer
Published: March 11, 2026
SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study.
Journal: Frontiers in cardiovascular medicine
Published: July 01, 2025
Long-term impact of COVID-19 in patients with lung cancer receiving immune checkpoint inhibitors: a multicenter cohort study during Omicron pandemic.
Journal: BMC infectious diseases
Published: March 31, 2024
Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China.
Journal: Clinical and translational medicine
Published: August 14, 2023
Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis.
Journal: Journal for immunotherapy of cancer
Published: May 09, 2023
Comprehensive nomogram models for predicting checkpoint inhibitor pneumonitis.
Journal: American journal of cancer research
Published: February 01, 2023
Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Journal: Frontiers in immunology
Published: January 25, 2022
Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis.
Journal: Frontiers in oncology
Published: December 01, 2021
Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.
Journal: Clinical lung cancer
Published: March 09, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026